Eversense 365 CGM: What Healthcare Professionals Need to Know | TCOYD

Описание: When it comes to diabetes management, every patient’s journey is unique. In this educational review, Dr. Edelman and Dr. Pettus, endocrinologists living with Type 1 diabetes, explore Eversense 365, an implantable CGM option that might suit specific patient needs.

Understanding diverse patient requirements in glucose monitoring, we discuss this FDA-cleared alternative: its 365 sensor duration, accuracy data (8.8% MARD), flexible wear features, and practical considerations for patient selection. As with any diabetes technology, it’s about finding the right fit for each individual.

Join us to learn:
Understanding accuracy metrics and calibration requirements
Flexible wear options, including waterproof capabilities
Discrete on-body vibration alerts for patient comfort
Skin-friendly adhesive design with less than 1% irritation rate
Three-step implementation process for your practice

Watch our video about implantable CGM:    • Eversense Implantable CGM: Another Option ...  
Discover the full video series: https://tcoyd.org/hcp-eversense/

Learn diabetes with TCOYD: https://tcoyd.org
Follow TCOYD's Instagram:   / tcoyd  
TCOYD's Facebook:   / tcoyd  
Listen to the podcast: https://tcoydthepodcast.transistor.fm

Dr. Edelman is on the Board of Directors at Senseonics

The information contained in or provided through TCOYD content is for purposes of general consumer education only, and though it is professional medical advice, always consult your doctor for medical diagnosis and treatment. The use of this information is your full responsibility with the understanding and agreement that TCOYD is not liable for claim, loss, or damage occurring as a result of its use.